Five things for pharma marketers to know: Monday, March 13, 2017


1. Amgen's PCSK9 inhibitor Repatha reduces the need for patients to undergo apheresis, a a time-consuming procedure that uses a machine to remove bad cholesterol from the patient's body. (Reuters)

2. President Donald Trump selected Dr. Scott Gottlieb as the new FDA commissioner. Gottlieb was the deputy commissioner for medical and scientific affairs at the FDA for President George W. Bush. Among other roles, he currently serves as an advisor to GlaxoSmithKline and Bristol-Myers Squibb. (Stat)

3. Acorda Therapeutics launched a skill with Amazon's Alexa that allows users to ask Alexa questions about multiple sclerosis. The skill pulls information from Acorda's MS Self mobile app. Skills refer to Alexa's built-in information-providing capabilities.

4. Rep. Elijah Cummings (D-MD) said that President Trump is “enthusiastic" about proposals that would allow Medicare to negotiate drug prices and the U.S. to import drugs from other countries. Cummings met with Trump last week. (Bloomberg)

5. The Brookings Institution estimates that at least 15 million people will lose their healthcare coverage under the American Health Care Act. The Congressional Budget Office is expected to provide more concrete data about coverage and the cost of the legislation sometime this week. (Axios)